Copyright © 2005, European Society of Cardiology
Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function
INSERM Unit 698, Cardiovascular Remodeling, CHU Xavier Bichat-Claude Bernard, 46, rue. Henri Huchard, 75877 Paris, cedex 18, France
* Corresponding author. Tel.: +33 140258600; fax: +33 140258602. Email address: jbmichel{at}bichat.inserm.fr
Objectives: Cell transplantation and associated neovascularization in vivo may be beneficial in ischemic disease. We hypothesized that transplanted mesothelial cells (MCs) could improve neovascularization in the post-myocardial infarct scar in rats.
Methods: Myocardial infarction was created by left coronary artery ligation in Lewis rats. After 3 weeks, surviving rats with left ventricular (LV) ejection fraction (EF) <50% were randomized into 2 groups which received, via injection into the infarct scar, either syngeneic rat peritoneal MCs (transplanted group) or vehicle alone (control group). Rats were followed-up echocardiographically for 4 weeks. Before transplantation, cells were transfected in vitro or labeled by a fluorescent dye for subsequent tracking in vivo. Transplanted cells and neovascularization were assessed histologically in the infarct scar by immunostaining or intravenous FITC-dextran injection prior to sacrifice, from 1 to 30 days post-transplantation.
Results: Among other pro-angiogenic chemokines, cultured MCs released stromal cell-derived factor (SDF-1
) (15.9 ± 1.8 µg/mg protein) in vitro. At 1 month, some transplanted MCs were visualized (surviving or proliferating) in the LV scar and were incorporated in new vessels. The transplanted rats presented an increased vascular density in the scar, improved LV-EF (44.0 ± 8.6% vs. 24.0 ± 4.5%, p<0.01) with decreased LV end-diastolic diameter (9.6 ± 0.6 vs. 11.1 ± 0.6 mm, p<0.01) and volume (0.47 ± 0.1 vs. 0.63 ± 0.1 ml, p<0.01) vs. controls. One week post-transplantation, higher levels of SDF-1 were extracted from LV peri-infarct tissue (32.3 ± 5.8 vs. 22.6 ± 3.1 pg/mg protein in controls, p<0.01).
Conclusions: Since autologous MCs can be obtained easily and cultured in large quantities, MC transplantation may represent a new angiogenic strategy in the prevention of ischemic remodeling.
KEYWORDS Remodeling; Gene transfer; Cell therapy; Angiogenesis; Contractile function
Time for primary review 32 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Ksiazek, J. Mikula-Pietrasik, S. Olijslagers, A. Jorres, T. von Zglinicki, and J. Witowski Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R374 - R382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-D. Huang, F.-L. Lu, X.-Y. Xu, X.-H. Liu, X.-X. Zhao, B.-Z. Zhao, L. Wang, D.-J. Gong, Y. Yuan, and Z.-Y. Xu Transplantation of angiogenin-overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1329 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chang, P.-H. Lai, C.-C. Wang, S.-C. Chen, W.-C. Chang, and H.-W. Sung Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial adhesions J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 867 - 874. [Abstract] [Full Text] [PDF]
|
|